vs
Encompass Health Corp（EHC）与Packaging Corporation of America（PKG）财务数据对比。点击上方公司名可切换其他公司
Packaging Corporation of America的季度营收约是Encompass Health Corp的1.5倍（$2.4B vs $1.5B），Encompass Health Corp净利率更高（9.5% vs 7.2%，领先2.2%），Packaging Corporation of America同比增速更快（10.6% vs 9.9%），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs 6.8%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Packaging Corporation of America是总部位于美国伊利诺伊州莱克福里斯特的制造企业，业务主要布局于美国本土，当前拥有约15500名员工，首席执行官为Mark W. Kowlzan。
EHC vs PKG — 直观对比
营收规模更大
PKG
是对方的1.5倍
$1.5B
营收增速更快
PKG
高出0.7%
9.9%
净利率更高
EHC
高出2.2%
7.2%
两年增速更快
EHC
近两年复合增速
6.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $2.4B |
| 净利润 | $146.1M | $170.9M |
| 毛利率 | — | 19.1% |
| 营业利润率 | 16.7% | 10.6% |
| 净利率 | 9.5% | 7.2% |
| 营收同比 | 9.9% | 10.6% |
| 净利润同比 | 20.8% | -16.1% |
| 每股收益（稀释后） | $1.43 | $1.91 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCPKG
| Q1 26 | — | $2.4B | ||
| Q4 25 | $1.5B | $2.4B | ||
| Q3 25 | $1.5B | $2.3B | ||
| Q2 25 | $1.5B | $2.2B | ||
| Q1 25 | $1.5B | $2.1B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.4B | $2.2B | ||
| Q2 24 | $1.3B | $2.1B |
净利润EHCPKG
| Q1 26 | — | $170.9M | ||
| Q4 25 | $146.1M | $101.9M | ||
| Q3 25 | $126.5M | $226.9M | ||
| Q2 25 | $142.1M | $241.5M | ||
| Q1 25 | $151.5M | $203.8M | ||
| Q4 24 | $120.9M | $221.2M | ||
| Q3 24 | $108.2M | $238.1M | ||
| Q2 24 | $114.1M | $198.9M |
毛利率EHCPKG
| Q1 26 | — | 19.1% | ||
| Q4 25 | — | 18.9% | ||
| Q3 25 | — | 21.8% | ||
| Q2 25 | — | 22.2% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 21.9% | ||
| Q3 24 | — | 23.1% | ||
| Q2 24 | — | 21.1% |
营业利润率EHCPKG
| Q1 26 | — | 10.6% | ||
| Q4 25 | 16.7% | 7.1% | ||
| Q3 25 | 14.9% | 14.0% | ||
| Q2 25 | 16.2% | 15.4% | ||
| Q1 25 | 16.4% | 13.1% | ||
| Q4 24 | 14.3% | 14.1% | ||
| Q3 24 | 13.6% | 15.0% | ||
| Q2 24 | 14.3% | 13.3% |
净利率EHCPKG
| Q1 26 | — | 7.2% | ||
| Q4 25 | 9.5% | 4.3% | ||
| Q3 25 | 8.6% | 9.8% | ||
| Q2 25 | 9.7% | 11.1% | ||
| Q1 25 | 10.4% | 9.5% | ||
| Q4 24 | 8.6% | 10.3% | ||
| Q3 24 | 8.0% | 10.9% | ||
| Q2 24 | 8.8% | 9.6% |
每股收益（稀释后）EHCPKG
| Q1 26 | — | $1.91 | ||
| Q4 25 | $1.43 | $1.14 | ||
| Q3 25 | $1.24 | $2.51 | ||
| Q2 25 | $1.39 | $2.67 | ||
| Q1 25 | $1.48 | $2.26 | ||
| Q4 24 | $1.18 | $2.45 | ||
| Q3 24 | $1.06 | $2.64 | ||
| Q2 24 | $1.12 | $2.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | — |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $2.4B | — |
| 总资产 | $7.1B | — |
| 负债/权益比越低杠杆越低 | 1.00× | — |
8季度趋势，按日历期对齐
现金及短期投资EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | $72.2M | $529.0M | ||
| Q3 25 | $48.7M | $634.0M | ||
| Q2 25 | $99.1M | $787.9M | ||
| Q1 25 | $95.8M | $751.7M | ||
| Q4 24 | $85.4M | $685.0M | ||
| Q3 24 | $147.8M | $676.6M | ||
| Q2 24 | $154.4M | $613.6M |
总债务EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | $2.4B | $4.0B | ||
| Q3 25 | $2.4B | $4.0B | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | $2.5B | ||
| Q3 24 | $2.3B | $2.5B | ||
| Q2 24 | $2.7B | — |
股东权益EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | $2.4B | $4.6B | ||
| Q3 25 | $2.4B | $4.8B | ||
| Q2 25 | $2.3B | $4.6B | ||
| Q1 25 | $2.2B | $4.5B | ||
| Q4 24 | $2.1B | $4.4B | ||
| Q3 24 | $2.0B | $4.3B | ||
| Q2 24 | $1.8B | $4.1B |
总资产EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | $7.1B | $10.7B | ||
| Q3 25 | $6.9B | $11.0B | ||
| Q2 25 | $6.8B | $9.0B | ||
| Q1 25 | $6.6B | $9.0B | ||
| Q4 24 | $6.5B | $8.8B | ||
| Q3 24 | $6.5B | $8.8B | ||
| Q2 24 | $6.4B | $9.0B |
负债/权益比EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | 1.00× | 0.87× | ||
| Q3 25 | 1.01× | 0.84× | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | 0.57× | ||
| Q3 24 | 1.20× | 0.58× | ||
| Q2 24 | 1.46× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | — |
| 自由现金流经营现金流 - 资本支出 | $116.7M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 14.8% | — |
| 现金转化率经营现金流/净利润 | 2.37× | — |
| 过去12个月自由现金流最近4个季度 | $439.2M | — |
8季度趋势，按日历期对齐
经营现金流EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | $346.0M | $446.6M | ||
| Q3 25 | $270.8M | $472.2M | ||
| Q2 25 | $270.2M | $299.6M | ||
| Q1 25 | $288.6M | $339.1M | ||
| Q4 24 | $278.8M | $325.4M | ||
| Q3 24 | $267.8M | $327.1M | ||
| Q2 24 | $217.4M | $278.3M |
自由现金流EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | $116.7M | $127.6M | ||
| Q3 25 | $83.7M | $280.1M | ||
| Q2 25 | $113.3M | $129.9M | ||
| Q1 25 | $125.5M | $191.0M | ||
| Q4 24 | $80.1M | $124.1M | ||
| Q3 24 | $120.3M | $180.4M | ||
| Q2 24 | $60.5M | $33.3M |
自由现金流率EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 5.4% | ||
| Q3 25 | 5.7% | 12.1% | ||
| Q2 25 | 7.8% | 6.0% | ||
| Q1 25 | 8.6% | 8.9% | ||
| Q4 24 | 5.7% | 5.8% | ||
| Q3 24 | 8.9% | 8.3% | ||
| Q2 24 | 4.6% | 1.6% |
资本支出强度EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | 14.8% | 13.5% | ||
| Q3 25 | 12.7% | 8.3% | ||
| Q2 25 | 10.8% | 7.8% | ||
| Q1 25 | 11.2% | 6.9% | ||
| Q4 24 | 14.1% | 9.4% | ||
| Q3 24 | 10.9% | 6.7% | ||
| Q2 24 | 12.1% | 11.8% |
现金转化率EHCPKG
| Q1 26 | — | — | ||
| Q4 25 | 2.37× | 4.38× | ||
| Q3 25 | 2.14× | 2.08× | ||
| Q2 25 | 1.90× | 1.24× | ||
| Q1 25 | 1.90× | 1.66× | ||
| Q4 24 | 2.31× | 1.47× | ||
| Q3 24 | 2.48× | 1.37× | ||
| Q2 24 | 1.91× | 1.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
PKG
暂无分部数据
